Jove
Visualize
Contact Us

Related Experiment Videos

Clostridium difficile--associated diarrhea.

Michael S Schroeder1

  • 1Kaiser Permanente, Family Medicine Residency Program, Fontana, California 92335, USA.

American Family Physician
|March 17, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026
Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026
Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026
Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026
Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Clostridium difficile infection causes millions of US cases of diarrhea and colitis annually. Early diagnosis and treatment, alongside preventive measures like judicious antibiotic use and hygiene, are crucial for managing this condition.

Area of Science:

  • Infectious Diseases
  • Gastroenterology
  • Microbiology

Background:

  • Clostridium difficile infection (CDI) affects millions annually in the US, with significant mortality.
  • Key risk factors include antibiotic use, advanced age, comorbidities, and immune response deficits.

Observation:

  • Enzyme immunoassays for C. difficile toxins A and B offer rapid (2-4 hours) and specific (93-100%) diagnosis.
  • Assay sensitivity varies (63-99%), and flexible sigmoidoscopy provides immediate diagnosis in severe cases.

Findings:

  • Enzyme immunoassays are the most common diagnostic method for C. difficile toxins.
  • Metronidazole or vancomycin are primary treatments, alongside antibiotic discontinuation when feasible.

Implications:

Related Experiment Videos

  • Prompt diagnosis and aggressive treatment are vital for managing CDI.
  • Preventive strategies emphasize antibiotic stewardship, infection control, and patient isolation.